Search Results - sars-cov-2

PubPharm (100)

1

Ivermectin to prevent Coronavirus : A pilot randomized placebo-controlled double-blind trial of single dose oral Ivermectin for post-exposure prophylaxis of SARS-CoV-2

in: WHO International Clinical Trials Registry Platform | 2023

2

3ACP Malawi: Enhancing access to COVID-19 tests. Africa, Asia, Americas COVID-19 Preparedness (3ACP) : Evaluating the acceptability and feasibility of COVID-19 testing and linkage including self-testing: linked prospective studies in Malawi

in: WHO International Clinical Trials Registry Platform | 2023

3

HERALD : COVID-19: A PHASE 2B/3, RANDOMIZED, OBSERVER-BLINDED, PLACEBO-CONTROLLED, MULTICENTER CLINICAL STUDY EVALUATING THE EFFICACY AND SAFETY OF INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS 18 YEARS OF AGE AND OLDER

in: WHO International Clinical Trials Registry Platform | 2023

4

Heberon Alfa R in COVID-19 : Use of Heberon® Alfa R in patients confirmed for infection with SARS-CoV-2 in Cuba. Observational clinical study. (COVID-19)

in: WHO International Clinical Trials Registry Platform | 2023

5

ATENEA-Co-300 study : Application of the CIGB 300 as Antiviral in the treatment of patients with a diagnosis of Covid 19. (COVID-19)

in: WHO International Clinical Trials Registry Platform | 2023

6

SOBERANA 02 : Phase I study, open, sequential and adaptive for evaluating the safety, reactogenicity and explore the immunogenicity of the prophylactic Vaccine Candidate FINLAY-FR-2 anti SARS-CoV-2 (COVID-19) - SOBERANA 02

in: WHO International Clinical Trials Registry Platform | 2023

7

MAMBISA Study : Adaptive phase I / II clinical trial, randomized, of parallel groups, to evaluate the safety and immunogenicity in adults of two vaccine candidates, based on recombinant RBD subunits for the prevention of COVID-19 in regimens that use the nasal route of administration. (COVID-19)

in: WHO International Clinical Trials Registry Platform | 2023

8

SOBERANA 02A : Phase II study, multicenter and adaptive for evaluating the immunogenicity, safety and reactogenicity of the Anti-SARS Prophylactic Vaccine Candidate - CoV - 2, FINLAY- FR-2 (COVID-19) - SOBERANA 02A

in: WHO International Clinical Trials Registry Platform | 2023

9

SOBERANA 01A : Phase I, randomized, double-blind and adaptive study to evaluate the safety, reactogenicity and explore the immunogenicity of different formulations of the Prophylactic Vaccine Candidates against SARS - CoV - 2, FINLAY- FR-1 and FINLAY- FR-1A (COVID-19). - SOBERANA 01A

in: WHO International Clinical Trials Registry Platform | 2023

10

CIGB-258 at COVID-19 : Administration of the CIGB-258 peptide in patients with COVID-19 under intensive therapy regimen (COVID-19)

in: WHO International Clinical Trials Registry Platform | 2023

1
2
3
4
5
6
7
8
9
10
Next »
[10]